Long-Term Liabilities: The sum of all non-current liabilities.
Kiora Pharmaceuticals, Inc. (KPRX) had Long-Term Liabilities of $4.72M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$16.02M |
|
$3.59M |
|
-- |
|
$16.02M |
|
$11.51M |
|
$4.51M |
|
$1.15M |
|
$5.66M |
|
$5.77M |
|
$3.59M |
|
$3.59M |
|
$3.59M |
|
$3.74M |
|
$4.51M |
|
$4.63M |
|
3.87M |
|
4.12M |
|
$0.93 |
|
$0.87 |
|
| Balance Sheet Financials | |
$29.71M |
|
$0.01M |
|
$6.78M |
|
$36.48M |
|
$6.01M |
|
-- |
|
|
Long-Term Liabilities |
$4.72M |
$10.72M |
|
$25.76M |
|
$19.07M |
|
$25.76M |
|
3.00M |
|
| Cash Flow Statement Financials | |
$8.56M |
|
$-22.66M |
|
$15.50M |
|
$2.46M |
|
$3.80M |
|
$1.34M |
|
$0.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
28.15% |
|
28.15% |
|
28.92% |
|
35.33% |
|
22.44% |
|
$8.55M |
|
-- |
|
-- |
|
-- |
|
0.44 |
|
-- |
|
18.38 |
|
19.86 |
|
13.95% |
|
18.85% |
|
9.85% |
|
13.95% |
|
$8.58 |
|
$2.07 |
|
$2.07 |
|